로딩 중…
지수 로딩 중…
Veraxa Biotech AG Ordinary Shares
VRXA· NASDAQ· Health Care
$1.13+15.31%
2026-10-29
Valuation Metrics
Veraxa Biotech AG Ordinary Shares's Market Cap is $154M. Ranked #3039 of 3,115 in US market (top 98%), #1404 of 1,472 on NASDAQ (top 95%) by Market Cap.
Investment Metrics(as of 2026-10-29)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $154M | US#3,039/3,115 |
| Employees | 8 | US#2,777/3,115 |
| Performance | ||
| 1M Return | -13.74% | US#3,015/3,115 |
| From 52W High | -95.87% | US#3,125/3,115 |
| 1Y MDD | -96.05% | US#3,124/3,115 |
| Trading | ||
| Volume | 361,828 shares | US#3,006/3,115 |
| Trading Value | $398010.00 | US#3,114/3,115 |
Company Info
Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp., focusing on developing next-generation cancer therapies such as antibody-drug conjugates (ADCs) and bispecific T-cell engagers. [64, 65]